{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": "219"
        },
        "variant_string_id": "PINK1 K219A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "D",
          "alt": "A",
          "position": "362"
        },
        "variant_string_id": "PINK1 D362A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "D",
          "alt": "A",
          "position": "384"
        },
        "variant_string_id": "PINK1 D384A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "K219A, D362A, D384A",
          "alt": "triple kinase-dead mutant",
          "position": "multiple"
        },
        "variant_string_id": "PINK1 triple kinase-dead mutant"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1's enzymatic activity is crucial for its function, and mutations impairing this activity are associated with Parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is related to loss of PINK1's kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay measures enzyme activity, directly relating to the disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assay is applicable as it measures enzymatic activity crucial for function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Three independent experiments with wild type and kinase-dead mutant controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic control (triple kinase-dead mutant) used.",
          "judgment": "Yes",
          "reasoning": "Variant controls are present.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Reduced activity compared to wild type, similar to pathogenic controls.",
          "judgment": "Pathogenic",
          "reasoning": "Significantly reduced activity supports pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant shows significantly reduced enzymatic activity, supporting its pathogenic role."
    }
  ]
}